Prevalence, management, and outcomes of haemorrhagic events in left ventricular assist device recipients.

ABSTRACT:

Aims

Left ventricular assist devices (LVADs) have reduced the mortality of patients with advanced heart failure both as bridge-to-transplant and as destination therapy. However, LVADs are associated with various complications, including bleedings, which affect the prognosis. The aim of the study was to explore the prevalence, management, and outcomes of haemorrhagic adverse events in LVAD recipients.

Methods and results

We conducted a retrospective, single-centre, cohort study including all patients who received an LVAD from January 2008 to December 2019 in our tertiary centre (Rangueil University Hospital, Toulouse, France). Bleeding events, death, and heart transplantation were collected from electronic medical files. Eighty-eight patients were included, and 43 (49%) prese

SUBMITTER: Pourtau L 

PROVIDER: S-EPMC9065835 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature